HaemaLogiX wins "Most Promising CAR-T Pipeline in APAC" at the Asia Pacific CGT¹ Excellence Awards 2025

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Honours
HaemaLogiX-Awarded

More Like This

HaemaLogiX Announces Appointment of Damian Clarke-Bruce as Managing Director and CEO

PR Newswire associated0

Gyala Therapeutics unveils first-in-class CAR-T therapy targeting CD84 showing strong preclinical efficacy in hard-to-treat leukemias

PR Newswire associated0

AvenCell Awarded Up to $40 Million AMED Grant to Advance Allogeneic CAR-T Program

PR Newswire associated0

Cellex Symposium 2025 Brings Together International Experts to Discuss the Evolving Field of Cell and Gene Therapy

Keymed Biosciences Announces the Latest Clinical Trial Results of CM336 Published in the New England Journal of Medicine

PR Newswire associated0

Kinomica to Present Research Abstract on a Multi-drug Biomarker Signature to Predict Best First-line Treatments for Acute Myeloid Leukemia (AML) at the 2024 ASCO Annual Meeting

How Cutting-Edge Immunotherapies Are Redefining Cancer Treatment Options

PR Newswire associated0

AvenCell Announces First Patient Dosed in a Phase IA Study with lead product candidate AVC-201, a Novel Allogeneic CD123-Directed Switchable CAR-T Investigational Therapy for the Treatment of Relapsed/Refractory Acute Myeloid Leukemia and other CD123 Hematological Malignancies